Your browser does not support JavaScript or it may be disabled!
rediff.com
 India As It Happens
Rediff Labs will showcase innovative products that rediff is working on behind the scenes.
News   |   Images
NEWS ON MOBILE
Get Realtime News
on your webpage

About 518 results for "amgen rank"

Top 7 Research Reports for July 29, 2016
Zacks.com

Top 7 Research Reports for July 29, 2016

Today's must-read reports are for Amgen (AMGN), JPMorgan (JPM) and Mondelez (MDLZ). Zacks Rank # 2 (Buy) rated Amgen's strong Q2 earnings report earlier this week - it beat on the top- and bottom-lines and guided higher - has helped the stock's ... Yahoo! Canada, 3 weeks ago
Top 6 Research Reports for June 29, 2016 Yahoo! Canada, 1 month ago
[x]  
Nasdaq

The Zacks Analyst Blog Highlights: Regeneron, BioMarin, AbbVie, Amgen and Biogen

For Immediate Release Chicago, IL August 12, 2016 Zacks.com announces the list of stocks featured in the Analyst Blog. Every day the Zacks Equity Research analysts discuss the latest news and events impacting stocks and the financial markets.
 Yahoo! Singapore1 week ago
[x]  

Zacks.com featured highlights: Wal-Mart Stores, Home Depot, Amgen, United Parcel Service and Intel

For Immediate Release Chicago, IL July 07, 2016 - Stocks in this week's article include: Wal-Mart Stores Inc. (WMT), Home Depot, Inc. (HD), Amgen Inc. (AMGN), United Parcel Service, Inc. ( UPS) and Intel Corporation (INTC). Screen of the ...
 Yahoo! Finance UK and Ireland1 month ago
[x]  
Zacks.com

American Funds Capital World Growth and Income C (CWGCX)

a Zacks Rank #2 (Buy) seeks long-term growth of capital while providing current income. CWGCX invests primarily in common stocks of well-established companies located around the world, many of which have the potential to pay dividends. This ...
 Yahoo! Singapore1 month ago Quick Guide to American Funds Capital World Growth and Income Fund 1 (CWGFX)  Yahoo! Finance UK and Ireland2 months ago
[x]  
Nasdaq

Amgen (AMGN) Tops Q2 Earnings & Revenues, Raises View

Biotech major, Amgen Inc. AMGN, reported second quarter 2016 earnings of $2.84 per share, well above the Zacks Consensus Estimate of $2.74 and up 11% from the year-ago period. Amgen Inc. (AMGN) Street Actual & Estimate EPS - Last 5 Quarters | ...
 Yahoo! Singapore3 weeks ago Amgen (AMGN) May Beat Q2 Earnings: Will the Stock Gain?  Zacks.com1 month ago Kite (KITE) Q2 Earnings: What's in Store for the Stock?  Zacks.com2 weeks ago Glaxo (GSK) Q2 Earnings: Can the Stock Pull a Surprise?  Yahoo! Singapore4 weeks ago
[x]  
Zacks.com

Biotech Earnings Battle: Gilead (GILD) vs. Amgen (AMGN)

In this video, we take a look at two of the biggest and most important companies in the biotech space. Both are reporting earnings this week, and given the volatile nature of the sector lately, it will definitely be in investors best interest to see ...
 Zacks.com4 weeks ago Biotech Earnings Battle: Biogen vs. Amgen  Zacks.com4 weeks ago
[x]  
Nasdaq

Zacks Industry Outlook Highlights: Bristol-Myers, Pfizer, Sanofi, Amgen and Biogen

For Immediate Release Chicago, IL July 25, 2016 Today, Zacks Equity Research discusses Pharma, including Bristol-Myers (BMY), Pfizer (PFE), Sanofi (SNY), Amgen (AMGN) and Biogen (BIIB). Industry: Pharma Link: ...
 Yahoo! Singapore4 weeks ago
[x]  
Nasdaq

Amgen and Daiichi Sankyo Team Up for Biosimilars in Japan

Amgen Inc. AMGN announced an exclusive agreement with Daiichi Sankyo Company, Limited for the commercialization of nine biosimilars in Japan including biosimilars of AbbVie's ABBV Humira and Roche Holding AG's RHHBY Avastin and Herceptin. The ...
 Yahoo! Singapore1 month ago
[x]  
Zacks.com

Amgen's Repatha Gains FDA Approval for New Dosing Option

Amgen Inc. AMGN announced that the FDA has approved a new, monthly single-dose administration option for its PCSK9 inhibitor, Repatha. The Repatha Pushtronex system, an on-body infusor with a prefilled cartridge, is a hands-free device intended to ...
 Yahoo! Singapore1 month ago
[x]  
Nasdaq

Amgen Humira Biosimilar Briefing Documents Look Good

Briefing documents issued by the FDA ahead of an advisory panel meeting for Amgen Inc.'s AMGN ABP 501, a biosimilar version of AbbVie Inc.'s ABBV Humira, look good. Amgen is seeking FDA approval for ABP 501 for indications for which Humira is ...
 Yahoo! 7 Finance1 month ago
[x]  
Prev | Next
Personalize your Realtimeclose [x]
Add content to your personalized tab - My News
Add upto 6 topics of your interest:
for eg.2g Scam , World
1.
2.
3.
4.
5.
6.
Personalize the tabs display. ( You can add or remove the tabs )
AlertsGet updates on latest news & your favourite topics right in your inbox.Set an Alert|Manage your Alerts

Get

Realtime News

on your Webpage

Add Widget >Get your members hooked!
    
Alerts
Get updated on latest news & your favorite topics right in your inbox!
Happening by Location Click on any location on map to view latest news by location
 
More     Less